Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
Lingkai Weng, Malvern, PA (US); Lei Qiao, Downingtown, PA (US); Jiacheng Zhou, Newark, DE (US); Pingli Liu, Newark, DE (US); and Yongchun Pan, Newark, DE (US)
Assigned to Incyte Holdings Corporation, Wilmington, DE (US); and Incyte Corporation, Wilmington, DE (US)
Filed by Incyte Corporation, Wilmington, DE (US); and Incyte Holdings Corporation, Wilmington, DE (US)
Filed on Aug. 18, 2022, as Appl. No. 17/820,779.
Application 13/793,864 is a division of application No. 12/469,360, filed on May 20, 2009, granted, now 8,420,645, issued on Apr. 16, 2013.
Application 17/820,779 is a continuation of application No. 17/014,414, filed on Sep. 8, 2020, granted, now 11,452,726.
Application 17/014,414 is a continuation of application No. 16/269,871, filed on Feb. 7, 2019, granted, now 10,799,509, issued on Oct. 13, 2020.
Application 16/269,871 is a continuation of application No. 15/355,630, filed on Nov. 18, 2016, granted, now 10,245,265, issued on Apr. 2, 2019.
Application 15/355,630 is a continuation of application No. 14/525,381, filed on Oct. 28, 2014, abandoned.
Application 14/525,381 is a continuation of application No. 13/793,864, filed on Mar. 11, 2013, granted, now 8,901,123, issued on Dec. 2, 2014.
Claims priority of provisional application 61/054,995, filed on May 21, 2008.
Prior Publication US 2023/0098850 A1, Mar. 30, 2023
1. A salt which is 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide dibenzenesulfonic acid salt, or a hydrate or solvate thereof.
14. A composition comprising the salt, or a hydrate or solvate thereof, of claim 1 and at least one pharmaceutically acceptable carrier.